Search

Your search keyword '"Kosma, V.-M. (Veli-Matti)"' showing total 65 results

Search Constraints

Start Over You searched for: Author "Kosma, V.-M. (Veli-Matti)" Remove constraint Author: "Kosma, V.-M. (Veli-Matti)"
65 results on '"Kosma, V.-M. (Veli-Matti)"'

Search Results

1. Rare germline copy number variants (CNVs) and breast cancer risk

2. Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices

3. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

5. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

6. Genome-wide association study of germline variants and breast cancer-specific mortality

7. Genetic architecture of human plasma lipidome and its link to cardiovascular disease

8. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

9. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

10. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma:a multicenter study

11. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

12. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

13. Body mass index and breast cancer survival:a Mendelian randomization analysis

14. Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk

15. Body mass index and breast cancer survival

16. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

17. Reproductive profiles and risk of breast cancer subtypes

18. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

19. PHIP:a novel candidate breast cancer susceptibility locus on 6q14.1

20. Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups

21. FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

22. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

23. Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers

24. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

25. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

26. Genetic predisposition to ductal carcinoma in situ of the breast

27. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

28. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

29. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

30. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

31. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

32. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

33. Prediction of breast cancer risk based on profiling with common genetic variants

34. A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

35. Identification of novel genetic markers of breast cancer survival

36. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

37. Common germline polymorphisms associated with breast cancer-specific survival

38. Annexin A1 expression in a pooled breast cancer series: Association with tumor subtypes and prognosis

39. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

40. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

41. Fine-scale mapping of the 4q24 locus identifies & pr two Independent loci associated with breast cancer risk

42. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

43. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

44. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

45. MicroRNA related polymorphisms and breast cancer risk

46. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

47. Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

48. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

49. 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

50. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: Evidence from the Breast Cancer Association Consortium

Catalog

Books, media, physical & digital resources